US Stock MarketDetailed Quotes
AGNPF ALGERNON PHARMACEUTICALS INC
- 0.091435
- +0.004235+4.86%
15min DelayClose Apr 26 16:00 ET
1.98MMarket Cap-446P/E (TTM)
0.091435High0.086500Low6.04KVolume0.086500Open0.087200Pre Close528.19Turnover0.03%Turnover RatioLossP/E (Static)21.64MShares0.20300052wk High2.69P/B1.98MFloat Cap0.03530052wk Low--Dividend TTM21.64MShs Float3.875000Historical High--Div YieldTTM5.66%Amplitude0.035000Historical Low0.087000Avg Price1Lot Size
ALGERNON PHARMACEUTICALS INC Key Stats
Quarterly+Annual
YOY
| (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | (Q3)May 31, 2022 | (Q2)Feb 28, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 93.53%-52.24K | 12.35%-2.55M | 61.08%-572.71K | 21.18%-732.94K | 48.22%-440.22K | -338.14%-807.14K | 62.77%-2.91M | -80.72%-1.47M | 48.54%-929.94K | 52.21%-850.12K |
| Net income from continuing operations | 72.26%-521.55K | -12.01%-6.78M | -13.95%-2.53M | -40.80%-1.13M | 32.05%-1.25M | -56.60%-1.88M | 21.72%-6.05M | -822.80%-2.22M | 52.17%-800.63K | 23.03%-1.84M |
| Operating gains losses | -56.82%10.82K | 263.89%73.95K | 162.81%13.65K | 35,770.27%13.27K | 255.08%21.97K | 370.68%25.05K | -248.48%-45.12K | 77.21%-21.73K | -99.97%37 | -133.35%-14.17K |
| Depreciation and amortization | -36.46%7.43K | 44.26%50.4K | -53.00%13.34K | 552.70%12.83K | 173.23%12.54K | --11.69K | --34.94K | --28.38K | --1.97K | --4.59K |
| Other non cash items | ---- | --40K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -13.05%382.03K | -51.03%1.27M | -41.81%275.59K | 219.59%174.15K | -46.79%376.64K | -71.63%439.34K | 532.28%2.58M | 305.05%473.58K | 60.77%-145.63K | 145.38%707.79K |
| -Change in receivables | -81.98%81.72K | -64.83%567.8K | 84.60%-25.22K | 151.42%18.58K | 178.94%121.01K | -76.96%453.43K | 240.31%1.61M | -139.81%-163.71K | 92.38%-36.14K | 58.80%-153.29K |
| -Change in prepaid assets | -74.43%85.45K | 215.37%634.37K | 93.55%-37.24K | 1,582.20%82.53K | 377.09%254.93K | 1,737.27%334.15K | -398.61%-549.84K | -358.31%-577.3K | 96.06%-5.57K | -73.81%53.44K |
| -Change in payables and accrued expense | 153.44%186.11K | -95.82%63.54K | -72.17%338.05K | 170.28%73.04K | -99.91%702 | 12.60%-348.25K | 312.28%1.52M | 240.30%1.21M | -142.55%-103.92K | 76.93%807.64K |
| -Change in other working capital | --28.75K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 93.53%-52.24K | 12.35%-2.55M | 61.08%-572.71K | 21.18%-732.94K | 48.22%-440.22K | -338.14%-807.14K | 62.77%-2.91M | -80.72%-1.47M | 48.54%-929.94K | 52.21%-850.12K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 58.85%-59.5K | 88.63%-5.58K | -151.17%-27.01K | 79.50%-9.17K | 55.71%-17.74K | -16.20%-144.61K | -372.51%-49.07K | 86.99%-10.76K | -77.81%-44.74K |
| Net intangibles purchase and sale | --0 | 58.85%-59.5K | 88.63%-5.58K | -151.17%-27.01K | 79.50%-9.17K | 55.71%-17.74K | -16.20%-144.61K | -372.51%-49.07K | 86.99%-10.76K | -77.81%-44.74K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 58.85%-59.5K | 88.63%-5.58K | -151.17%-27.01K | 79.50%-9.17K | 55.71%-17.74K | -16.20%-144.61K | -372.51%-49.07K | 86.99%-10.76K | -77.81%-44.74K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -35.34%1.33M | -86.90%269.17K | 974K | -17.18K | 102.93K | -51.59%2.06M | 3,725.00%2.06M | 0 | 0 |
| Net common stock issuance | ---- | -40.35%1.23M | -91.86%167.25K | --1.05M | ---- | ---- | -23.70%2.06M | 5,037.81%2.06M | --0 | ---- |
| Proceeds from stock option exercised by employees | --0 | --102.93K | --0 | --0 | --0 | --102.93K | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---80.2K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -35.34%1.33M | -86.90%269.17K | --974K | ---17.18K | --102.93K | -51.59%2.06M | 3,725.00%2.06M | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -91.12%125.09K | -41.58%1.41M | -50.25%434.23K | -87.84%220.59K | -74.43%689.7K | -41.58%1.41M | -60.61%2.41M | -73.45%872.84K | -40.44%1.81M | 1.80%2.7M |
| Current changes in cash | 92.76%-52.24K | -28.07%-1.28M | -157.84%-309.12K | 122.75%214.05K | 47.86%-466.58K | -341.55%-721.95K | 72.93%-1M | 160.64%534.44K | -459.84%-940.69K | -329.25%-894.86K |
| Effect of exchange rate changes | -57.75%1.33K | 140.89%175 | -102.12%-26 | -278.48%-398 | -122.83%-2.54K | 124.14%3.14K | 94.91%-428 | -73.04%1.23K | 101.26%223 | 143.95%11.11K |
| End cash Position | -89.25%74.17K | -91.12%125.09K | -91.12%125.09K | -50.25%434.23K | -87.84%220.59K | -74.43%689.7K | -41.58%1.41M | -41.58%1.41M | -73.45%872.84K | -40.44%1.81M |
| Free cash flow | 93.67%-52.24K | 14.55%-2.61M | 61.97%-578.29K | 19.21%-759.95K | 49.78%-449.39K | -375.99%-824.88K | 61.53%-3.06M | -84.39%-1.52M | 50.22%-940.69K | 50.39%-894.86K |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg